Pengfei Ren
-
- Cancer Genomics and Diagnostics 4
-
- Glycosylation and Glycoproteins Research 4
-
- Monoclonal and Polyclonal Antibodies Research 7
- Radiomics and Machine Learning in Medical Imaging 2
-
- Lung Cancer Treatments and Mutations 8
- Lung Cancer Diagnosis and Treatment 3
-
- HER2/EGFR in Cancer Research 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Co-authors
- Jianhang JiaoMinfei WuYang WangLiping DaiYongjun GuoGuanjie ZhaoJie MaBing Wei
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Pengfei Ren
25 papers receiving 470 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 130
- Immunology 93
- Molecular Biology 289
- Biological Psychiatry 10
- Radiology, Nuclear Medicine and Imaging 84
Countries citing papers authored by Pengfei Ren
This map shows the geographic impact of Pengfei Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengfei Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengfei Ren more than expected).
Fields of papers citing papers by Pengfei Ren
This network shows the impact of papers produced by Pengfei Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengfei Ren. The network helps show where Pengfei Ren may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pengfei Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 8 | |
| 5 | 2022 | 1 | |
| 6 | 2021 | 5 | |
| 7 | 2020 | 78 | |
| 8 | 2020 | 5 | |
| 9 | 2020 | 12 | |
| 10 | 2020 | 41 | |
| 11 | 2019 | 11 | |
| 12 | 2019 | 3 | |
| 13 | 2019 | 48 | |
| 14 | 2018 | 19 | |
| 15 | 2016 | 26 | |
| 16 | 2014 | 17 | |
| 17 | 2014 | 47 | |
| 18 | 2012 | 6 | |
| 19 | 2012 | 36 | |
| 20 | 2012 | 34 |
About Pengfei Ren
Pengfei Ren is a scholar working on Cancer Research, Radiology, Nuclear Medicine and Imaging and Hepatology, having authored 26 papers that have together received 474 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Glycosylation and Glycoproteins Research (4 papers), Cancer Genomics and Diagnostics (4 papers), Lung Cancer Diagnosis and Treatment (3 papers), HER2/EGFR in Cancer Research (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Cancer Research (130 citations), Immunology (93 citations) and Molecular Biology (289 citations). Pengfei Ren has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Jianhang Jiao, Minfei Wu, Yang Wang, Liping Dai, Yongjun Guo, Guanjie Zhao, Jie Ma, Bing Wei, Chao Shi and Jiuzhou Zhao. Their work appears in journals such as PLoS ONE, Analytical Chemistry and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.